Natalizumab-associated reversible encephalopathy syndrome mimicking progressive multifocal leukoencephalopathy

Multiple Sclerosis Journal

Volumn 19, Issue 2, 2013, Pages 249-251

  Décard, Bernhard F ^a   Haghikia, Aiden ^a,b   Tönnes, Christina ^a   Thöne, Jan ^a   Lukas, Carsten ^a   Chan, Andrew ^a   Gold, Ralf ^a  

^a ST JOSEF HOSPITAL   (Germany)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Multiple sclerosis; natalizumab; progressive multifocal leukencephalopathy; reversible encephalopathy syndrome

Indexed keywords

CLONIDINE; ETIRACETAM; GLATIRAMER; MEFLOQUINE; MIRTAZAPINE; NATALIZUMAB; TRIAMCINOLONE;

ADULT; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; LOADING DRUG DOSE; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; QUADRIPLEGIA;

EID: 84873653212     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458512448268     Document Type: Article

References (9)

1. Major EO. Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annu Rev Med. 2010 ; 61: 35-47
2. Clifford DB, De Luca A, Simpson DM, et al. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: Lessons from 28 cases. Lancet Neurol. 2010 ; 9: 438-446
3. Vermersch P, Kappos L, Gold R, et al. Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy. Neurology. 2011 ; 76: 1697-1704
4. Lee VH, Wijdicks EF, Manno EM, Rabinstein AA. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol. 2008 ; 65: 205-210
5. Wenning W, Haghikia A, Laubenberger J, et al. Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. N Engl J Med. 2009 ; 361: 1075-1080
6. Brickelmaier M, Lugovskoy A, Kartikeyan R, et al. Identification and characterization of mefloquine efficacy against JC virus in vitro. Antimicrob Agents Chemother. 2009 ; 53: 1840-1849
7. Schroder A, Lee DH, Hellwig K, et al. Successful management of natalizumab-associated progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient with multiple sclerosis. Arch Neurol. 2010 ; 67: 1391-1394
8. Sanchez-Carteyron A, Alarcia R, Ara JR, et al. Posterior reversible encephalopathy syndrome after rituximab infusion in neuromyelitis optica. Neurology. 2010 ; 74: 1471-1473
9. Incecik F, Herguner MO, Altunbasak S, et al. Reversible posterior encephalopathy syndrome due to intravenous immunoglobulin in a child with Guillain-Barre syndrome. J Pediatr Neurosci. 2011 ; 6: 138-140